Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-919-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Ames test (OECD 471): negative with and without metabolic activation in S. typhimurium TA 1535, TA 1537, TA 100 and TA 98, and E. coli WP2 uvrA and WP2 uvrA pKM 101
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 30 Jul - 07 Aug 2007
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- The analytical purity of the test substance was not reported.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted Jul 1997
- Deviations:
- yes
- Remarks:
- analytical purity of the test substance was not reported
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- yes
- Remarks:
- analytical purity of the test substance was not reported
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Direccion General de Farmacia y Productos Sanitarios, Consejera de Sanidad y Consumo, Madrid, Spain
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- his operon
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A pKM 101
- Metabolic activation:
- with and without
- Metabolic activation system:
- Cofactor supplemented post-mitochondrial fraction (S9-mix), prepared from the livers of rats treated with Aroclor 1254
- Test concentrations with justification for top dose:
- 0.05, 0.15, 0.5, 1.5, 5 µL/plate, with and without metabolic activation
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: no data
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- solvent type not reported
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-nitrofluorene, sodium azide, 9-aminoacridine, 4-nitroquinoline-N-oxide, 2-aminoanthracene
- Remarks:
- See 'Any other information on material and methods incl. tables' for details on positive controls
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation); if the first assay result was negative the second assay was performed as a preincubation assay, and if the first assay result was positive the second assay was performed as a plate incorporation assay
DURATION
- Preincubation period: 20 min (second assay)
- Exposure duration: 48 hrs
NUMBER OF REPLICATIONS: 3 replications in 2 independent assays
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Evaluation criteria:
- A test substance is considered positive (mutagenic) in the test if:
It induces a dose-resonse in the range tested and/or
a reproducible increase at one or more concentrations in the number of revertant colonies per plate in at least one strain with ot without mutagenic activation is observed. - Statistics:
- Mean values and standard deviation were calculated.
- Key result
- Species / strain:
- S. typhimurium, other: TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A pKM 101
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: no precipitation was observed at any dose level, with and without metabolic activation.
COMPARISON WITH HISTORICAL CONTROL DATA: yes, the negative control and test substance results fell within the historical control data range (see Table 1 under 'Any other information on material and methods incl. tables').
ADDITIONAL INFORMATION ON CYTOTOXICITY: no cytotoxicity was observed up to and including the highest dose level, which is the limit dose level recommended in the OECD 471 guideline.
OTHER: Only 2-amino anthracene was used as a positive control, however, dilutions of the sample S9-mix were tested and confirmed to activate benzo(a)pyrene and 2-amino anthracene. - Conclusions:
- CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 11 - 20 Mar 1998
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- his operon
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Cofactor supplemented post-mitochondrial fraction (S9-mix), prepared from the livers of rats treated with Aroclor 1254
- Test concentrations with justification for top dose:
- 10, 33, 100, 333 and 1000 µg/plate, with and without metabolic activation
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: ethanol
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- ethanol
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- sodium azide
- methylmethanesulfonate
- other: daunomycine, 2-aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: 3 replications in 2 independent experiments
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth (reduction of bacterial background lawn, increase in size of the microcolonies, reduction of the revertant colonies)
OTHER:
the results of the dose range-finding test were included as part of experiment 1 - Evaluation criteria:
- A Salmonella typhimurium reverse mutation assay and/or Escherichia coli reverse mutation assay is considered acceptable if it meets the following
criteria:
a) The negative control data (number of spontaneous revertants per plate) should be within the laboratory background historical range for each tester strain (see Table 1)
b) The positive control chemicals should produce responses in all tester strains which are within the laboratory historical range documented for each positive control substance. Furthermore, the mean plate count should be at least two times the concurrent vehicle control group mean
c) The selected dose range should include a clearly toxic concentration or should exhibit limited solubility as demonstrated by the preliminary toxicity range-finding test or should extend to 5 mg/plate.
A test substance is considered negative (not mutagenic) in the test if:
a) The total number of revertants in any tester strain at any concentration is not greater than two times the solvent control value, with or without metabolic activation
b) The negative response should be reproducible in at least one independently repeated experiment.
A test substance is considered positive (mutagenic) in the test if:
a) It induces at least a 2-fold, dose related increase in the number of revertants compared to the solvent control value in any of the tester strains, either with or without metabolic activation. However, any plate with a mean plate count of less than 20 colonies is considered to be not significant and the result will be disregarded.
b) The positive response should be reproducible in at least one independently repeated experiment.
The preceding criteria were not absolute and other modifying factors might enter into the final evaluation decision. - Key result
- Species / strain:
- S. typhimurium, other: TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: precipitation was observed in all strains, with and without metabolic activation, from 1000 µg/plate and above.
RANGE-FINDING/SCREENING STUDIES:
A dose range-finding test with strain TA100 and the WP2uvrA strain (both with and without S9- mix) was performed to select suitable doses for the main experiments. Eight concentrations (3, 10, 33, 100, 333, 1000, 3330, 5000 µg/plate) were tested in triplicate. The results were reported as a part of the first experiment of the mutation assay. The highest concentration of the test substance used in the main experiments was the level at which the test substance exhibited limited solubility. Precipitation was observed on the plates from 1000 µg/plate and above in both strains.
COMPARISON WITH HISTORICAL CONTROL DATA: yes, the spontaneous mutation rate of each tester strain per plate were within the characteristic spontaneous mutation range (see Table 1 under 'Any other information on materials and methods incl. tables'), with the exception of TA 100 without metabolic activation. The value was slightly outside the limit of the range, therefore the validity of the test was considered not to be affected.
ADDITIONAL INFORMATION ON CYTOTOXICITY: no cytotoxicity was observed at any concentration level, with or without metabolic activation (see Table 2 and 3). - Conclusions:
- CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
Referenceopen allclose all
Table 2. Test results of experiment 1 (plate incorporation method)
With or without S9-Mix |
Test substance concentration (μL/plate) |
Mean number of revertant colonies per plate (average of 3 plates ± Standard deviation) |
||||
Base-pair substitution type |
Frameshift type |
|||||
TA 100 |
TA1535 |
WP2 uvR |
TA98 |
TA1537 |
||
- |
Solvent |
49.7 ± 26.1 |
14.7 ± 1.5 |
76.0 ± 8.2 |
14.7 ± 2.5 |
27.3 ± 5.5 |
- |
0.05 |
41.0 ± 4.0 |
14.7 ± 3.8 |
77.3 ± 22.9 |
21.3 ± 3.8 |
28.0 ± 8.9 |
- |
0.15 |
37.7 ± 3.8 |
11.0 ± 1.0 |
59.7 ± 7.2 |
16.0 ± 7.1 |
29.0 ± 3.0 |
- |
0.5 |
36.3 ± 6.8 |
13.3 ± 3.1 |
59.7 ± 4.9 |
20.0 ± 4.6 |
40.0 ± 21.0 |
- |
1.5 |
42.7 ± 4.7 |
12.0 ± 2.6 |
55.7 ± 21.1 |
16.3 ± 4.9 |
34.3 ± 9.6 |
- |
5.0 |
47.3 ± 10.1 |
10.3 ± 2.1 |
43.3 ± 18.1 |
17.0 ± 1.0 |
37.3 ± 8.6 |
Positive controls, –S9 |
Name |
NaN3 |
NaN3 |
4 -NNO |
2-NF |
9-AA |
Concentrations positive controls (μg/plate) |
10 |
30 |
7 |
90 |
100 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
556.3 ± 55.2 |
184.7 ± 46.8 |
610.0 ± 30.3 |
399.3 ± 25.0 |
215.0 ± 1.0 |
|
+ |
Solvent |
44.0 ± 2.0 |
15.7 ± 7.4 |
71.7 ± 14.7 |
20.3 ± 4.7 |
8.7 ± 3.1 |
+ |
0.05 |
52.0 ± 6.1 |
14.3 ± 7.8 |
90.7 ± 17.5 |
27.7 ± 1.5 |
10.0 ± 5.6 |
+ |
0.15 |
67.0 ± 14.7 |
15.3 ± 5.1 |
76.0 ± 39.9 |
27.0 ± 5.3 |
5.7 ± 2.1 |
+ |
0.5 |
47.0 ± 10.1 |
15.7 ± 3.5 |
87.3 ± 29.9 |
26.3 ± 5.0 |
8.7 ± 0.6 |
+ |
1.5 |
49.7 ± 13.3 |
10.7 ± 1.2 |
80.7 ± 24.0 |
21.7 ± 4.5 |
9.0 ± 2.6 |
+ |
5.0 |
61.3 ± 9.0 |
10.7 ± 2.5 |
64.7 ± 29.7 |
19.7 ± 4.7 |
7.0 ± 4.6 |
Positive controls, +S9 |
Name |
2-AA |
2-AA |
2-AA |
2-AA |
2-AA |
Concentrations (μL/plate) |
10 |
30 |
7 |
10 |
30 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
305.0 ± 41.6 |
326.0 ± 10.8 |
320.0 ± 6.2 |
611.3 ± 108.1 |
320.0 ± 6.2 |
2-NF: 2-nitrofluorene
NaN3: sodium azide
9-AA: 9-aminoacridine
4-NNO: 4-nitroquinoline-N-oxide
2-AA: 2-aminoanthracene
Table 3. Test results of experiment 2 (preincubation method)
With or without S9-Mix |
Test substance concentration (μL/plate) |
Mean number of revertant colonies per plate (average of 3 plates ± Standard Deviation ) |
||||
Base-pair substitution type |
Frameshift type |
|||||
TA 100 |
TA1535 |
WP2 uvR |
TA98 |
TA1537 |
||
- |
Solvent |
64.3 ± 5.1 |
9.7 ± 5.5 |
74.7 ± 19.0 |
22.7 ± 6.5 |
9.7 ± 3.2 |
- |
0.05 |
39.0 ± 1.0 |
12.3 ± 5.8 |
113.0 ± 15.7 |
23.3 ± 3.1 |
11.3 ± 3.1 |
- |
0.15 |
44.3 ± 4.2 |
12.3 ± 5.0 |
103.7 ± 17.6 |
24.0 ± 2.0 |
11.0 ± 3.5 |
- |
0.5 |
38.7 ± 14.2 |
9.0 ± 6.9 |
116.3 ± 10.8 |
22.7 ± 2.1 |
10.7 ± 1.5 |
- |
1.5 |
34.0 ± 3.0 |
16.7 ± 4.9 |
107.3 ± 10.1 |
29.3 ± 7.6 |
11.7 ± 5.5 |
- |
5.0 |
43.3 ± 10.7 |
10.0 ± 2.6 |
116.7 ± 10.1 |
19.3 ± 9.9 |
11.0 ± 5.2 |
Positive controls, –S9 |
Name |
NaN3 |
NaN3 |
4-NNO |
2-NF |
9-AA |
Concentrations (μL/plate) |
10 |
30 |
7 |
90 |
100 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
580.0 ± 8.2 |
504.0 ± 27.6 |
810.0 ± 77.3 |
544.3 ± 417.5 |
682.7 ± 91.5 |
|
+ |
Solvent |
47.0 ± 9.8 |
17.7 ± 5.5 |
45.3 ± 5.9 |
15.0 ± 4.0 |
19.3 ± 9.1 |
+ |
0.05 |
52.0 ± 6.6 |
18.0 ± 3.0 |
74.0 ± 5.6 |
17.3 ± 3.8 |
25.7 ± 1.5 |
+ |
0.15 |
51.3 ± 9.0 |
13.0 ± 7.9 |
80.0 ± 6.1 |
18.0 ± 4.4 |
24.7 ± 8.7 |
+ |
0.5 |
58.7 ± 8.5 |
16.0 ± 5.0 |
63.7 ± 14.5 |
17.7 ± 1.5 |
18.7 ± 3.1 |
+ |
1.5 |
58.7 ± 4.2 |
19.0 ± 6.2 |
76.0 ± 18.0 |
14.0 ± 3.6 |
18.3 ± 6.0 |
+ |
5.0 |
56.3 ± 4.1 |
15.7 ± 3.1 |
78.7 ± 26.1 |
16.0 ± 4.4 |
32.0 ± 6.9 |
Positive controls, +S9 |
Name |
2-AA |
2-AA |
2-AA |
2-AA |
2-AA |
Concentrations (μL/plate) |
10 |
30 |
7 |
10 |
30 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
352.7 ± 62.0 |
284.7 ± 11.7 |
475.7 ± 84.4 |
299.7 ± 79.6 |
161.7 ± 27.5 |
2-NF: 2-nitrofluorene
NaN3: sodium azide
9-AA: 9-aminoacridine
4-NNO: 4-nitroquinoline-N-oxide
2 -AA: 2 -aminoanthracene
Table 2: Results of experiment 1
With or without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates ± SD) |
||||
Base-pair substitution type |
Frameshift type |
|||||
TA 100 |
TA 1535 |
WP2 uvrA |
TA 98 |
TA 1537 |
||
-S9 |
ethanol |
55 ± 3 |
12 ± 3 |
14 ± 6 |
16 ± 2 |
6 ± 1 |
-S9 |
3 |
55 ± 6 |
- |
11 ± 2 |
- |
- |
-S9 |
10 |
63 ± 7 |
10 ± 4 |
10 ± 3 |
15 ± 6 |
7 ± 2 |
-S9 |
33 |
49 ± 7 |
8 ± 3 |
11 ± 1 |
16 ± 1 |
7 ± 4 |
-S9 |
100 |
59 ± 2 |
8 ± 1 |
12 ± 2 |
15 ± 3 |
5 ± 3 |
-S9 |
333 |
57 ± 7 |
7 ± 2 |
11 ± 6 |
17 ± 4 |
5 ± 3 |
-S9 |
1000 SP |
70 ± 6 |
10 ± 3 |
10 ± 2 |
16 ± 1 |
4 ± 1 |
-S9 |
3300 SP |
77 ± 9 |
- |
12 ± 2 |
- |
- |
-S9 |
5000 SP |
59 ± 13 |
- |
10 ± 4 |
- |
- |
Positive controls, –S9 |
Name |
MMS |
SA |
4-NQO |
DM |
9-AC |
Concentrations (μg/plate) |
650 |
1 |
10 |
4 |
60 |
|
|
529 ± 23 |
121 ± 18 |
291 ± 26 |
375 ± 36 |
185 ± 66 |
|
|
|
|
|
|
|
|
+S9 |
ethanol |
71 ± 3 |
8 ± 2 |
10 ± 1 |
26 ± 2 |
8 ± 1 |
+S9 |
3 |
66 ± 10 |
|
11 ± 4 |
|
|
+S9 |
10 |
62 ± 3 |
9 ± 2 |
9 ± 4 |
25 ± 4 |
8 ± 3 |
+S9 |
33 |
64 ± 3 |
9 ± 3 |
14 ± 3 |
22 ± 2 |
6 ± 2 |
+S9 |
100 |
50 ± 8 |
9 ± 3 |
15 ± 3 |
24 ± 5 |
6 ± 2 |
+S9 |
333 |
45 ± 5 |
13 ± 4 |
10 ± 3 |
18 ± 4 |
6 ± 4 |
+S9 |
1000 SP |
54 ± 8 |
12 ± 4 |
12 ± 6 |
23 ± 5 |
8 ± 1 |
+S9 |
3330 SP |
54 ± 9 |
- |
12 ± 1 |
- |
- |
+S9 |
5000 SP |
51 ± 9 |
- |
12 ± 2 |
- |
- |
Positive controls, +S9 |
Name |
2-AA |
2-AA |
2-AA |
2-AA |
2-AA |
Concentrations (μg/plate) |
1 |
2.5 |
5 |
2.5 |
2.5 |
|
|
1182 ± 90 |
240 ± 8 |
88 ± 10 |
1047 ± 57 |
713 ± 149 |
MMS = methylmethanesulfonate
SA = sodium azide
4-NQO = 4-nitroquinoline-N-oxide
9-AC = 9-aminoacridine
DM = daunomycine
2-AA = 2-aminoanthracene
SP = slight precipitate
Table 3: Results of experiment 2
With or without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates ± SD) |
||||
Base-pair substitution type |
Frameshift type |
|||||
TA 100 |
TA 1535 |
WP2 uvrA |
TA 98 |
TA 1537 |
||
-S9 |
ethanol |
88 ± 10 |
10 ± 2 |
10 ± 6 |
22 ± 7 |
5 ± 2 |
-S9 |
10 |
94 ± 13 |
9 ± 3 |
9 ± 2 |
17 ± 2 |
7 ± 3 |
-S9 |
33 |
93 ± 3 |
8 ± 3 |
12 ± 2 |
17 ± 3 |
5 ± 1 |
-S9 |
100 |
90 ± 7 |
10 ± 3 |
9 ± 2 |
14 ± 5 |
5 ± 3 |
-S9 |
333 |
90 ± 9 |
6 ± 3 |
11 ± 3 |
15 ± 6 |
5 ± 1 |
-S9 |
1000 SP |
77 ± 5 |
6 ± 3 |
9 ± 4 |
14 ± 4 |
7 ± 4 |
Positive controls, –S9 |
Name |
MMS |
SA |
4-NQO |
DM |
9-AC |
Concentrations (μg/plate) |
650 |
1 |
10 |
4 |
60 |
|
|
714 ± 49 |
152 ± 10 |
936 ± 118 |
598 ± 16 |
251 ± 100 |
|
|
|
|
|
|
|
|
+S9 |
ethanol |
99 ± 8 |
8 ± 4 |
11 ± 7 |
15 ± 1 |
7 ± 3 |
+S9 |
10 |
98 ± 10 |
8 ± 3 |
7 ± 1 |
17 ± 3 |
4 ± 2 |
+S9 |
33 |
103 ± 21 |
6 ± 3 |
8 ± 2 |
27 ± 6 |
7 ± 1 |
+S9 |
100 |
98 ± 9 |
8 ± 3 |
13 ± 7 |
21 ± 7 |
6 ± 2 |
+S9 |
333 |
93 ± 6 |
7 ± 5 |
8 ± 3 |
20 ± 5 |
8 ± 2 |
+S9 |
1000 SP |
112 ± 2 |
9 ± 3 |
8 ± 1 |
23 ± 1 |
4 ± 1 |
Positive controls, +S9 |
Name |
2-AA |
2-AA |
2-AA |
2-AA |
2-AA |
Concentrations (μg/plate) |
1 |
2.5 |
5 |
2.5 |
2.5 |
|
|
2235 ± 60 |
322 ± 15 |
406 ± 20 |
1732 ± 115 |
703 ± 41 |
MMS = methylmethanesulfonate
SA = sodium azide
4-NQO = 4-nitroquinoline-N-oxide
9-AC = 9-aminoacridine
DM = daunomycine
2-AA = 2-aminoanthracene
SP = slight precipitate
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Analogue justification
No data on the genetic toxicity of Fatty acids, C18-unsaturated, 2-hexyldecyl ester (old CAS 94278-07-6) are available. The assessment was therefore based on studies conducted with analogue substances as part of a read across approach, which is in accordance with Regulation (EC) No. 1907/2006, Annex XI, 1.5. For each specific endpoint the source substance(s) structurally closest to the target substance is/are chosen for read-across, with due regard to the requirements of adequacy and reliability of the available data. Structural similarities and similarities in properties and/or activities of the source and target substance are the basis of read-across. A detailed justification for the analogue read-across approach is provided in the technical dossier (see IUCLID Section 13).
Genetic toxicity (mutagenicity) in bacteria in vitro
CAS 22766-83-2
The in vitro genetic toxicity of 2-octyldodecyl myristate (CAS 22766-83-2) was assessed in a bacterial reverse mutation assay (Ames test) (WoE, 2007). The study was performed according to OECD guideline 471 and under GLP conditions. The plate incorporation method was applied in the first experiment and the preincubation method in the second experiment, using S. typhimurium strains TA 1535, TA 1537, TA 98 and TA 100, and E. coli WP2 uvrA pKM 101. All the strains were tested at concentrations up to and including the limit value of 5 µL/plate. No cytotoxicity was observed, with and without metabolic activation. The negative and positive controls were valid. The test substance did not induce an increase in reversions in the S. typhimurium and E.coli strains, with or without metabolic activation.
CAS 93803-87-3
The in vitro genetic toxicity of 2-octyldodecyl isooctadecanoate (CAS 93803-87-3) was assessed in a bacterial reverse mutation assay (Ames test), performed according to OECD guideline 471 and in compliance with GLP (WoE, 1998). S. typhimurium strains TA 1535, TA 1537, TA 98 and TA 100, and E. coli WP2 uvrA were exposed to the test substance at concentrations up to and including 1000 µg/plate (TA 1535, TA 98 and TA 1537) and 5000 µg/plate (TA 100 and E.coli WP2 uvrA), using the plate incorporation method in two independent experiments. Precipitation was observed in the medium at 1000 µg/plate and above in all strains, with and without metabolic activation. The positive and solvent controls were shown to be valid. The test substance did not induce reversions in the S. typhimurium strains or E. coli strain, with or without metabolic activation.
Overall conclusion for genetic toxicity
There are no available studies on the genetic toxicity of the target substance.Therefore, analogue read-across from source substances was applied fromin vitro studies on gene mutations in bacterial cells. The results of the available in vitro studies were consistently negative. Based on the available data and following the analogue approach, Fatty acids, C18-unsaturated, 2-hexyldecyl ester (old CAS 94278-07-6) is not expected to be mutagenic in vitro.
Justification for classification or non-classification
According to Article 13 of Regulation (EC) No. 1907/2006 "General Requirements for Generation of Information on Intrinsic Properties of substances", information on intrinsic properties of substances may be generated by means other than tests e.g. from information from structurally related substances (grouping or read-across), provided that conditions set out in Annex XI are met. Annex XI, "General rules for adaptation of this standard testing regime set out in Annexes VII to X” states that “substances whose physicochemical, toxicological and ecotoxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity may be considered as a group, or ‘category’ of substances. This avoids the need to test every substance for every endpoint". Since the analogue concept is applied to Fatty acids, C18-unsaturated, 2-hexyldecyl ester (old CAS 94278-07-6), data will be generated from data for reference source substance(s) to avoid unnecessary animal testing. Additionally, once the analogue read-across concept is applied, substances will be classified and labelled on this basis.
The available Ames tests on source substances fulfil the standard information requirements given in Annex VII of Regulation (EC) 1272/2008 and are suitable for classification. Based on the analogue read-across approach, there is no indication that the target substance induces genetic toxicity. Nevertheless, no final decision on classification for genetic toxicity according to Regulation (EC) 1272/2008 can be made, as no information on mutagenicity and clastogenicity in mammalian cells/in vivo of read-across substances have been considered in the Annex VII dossier for Fatty acids, C18-unsaturated, 2-hexyldecyl ester.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)